Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccine Effectiveness of One Dose of the Nonavalent HPV Vaccine Among Young-adult Women in Sweden
NCT07314307Phase 4Active, not recruiting
- Sponsor
- Karolinska Institutet
- Start
- May 2021
- Primary completion
- Dec 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Karolinska Institutet. Started May 2021; status: active, not recruiting.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07314307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07314307.